GB201018125D0 - Peptide - Google Patents

Peptide

Info

Publication number
GB201018125D0
GB201018125D0 GBGB1018125.3A GB201018125A GB201018125D0 GB 201018125 D0 GB201018125 D0 GB 201018125D0 GB 201018125 A GB201018125 A GB 201018125A GB 201018125 D0 GB201018125 D0 GB 201018125D0
Authority
GB
United Kingdom
Prior art keywords
peptide
nucleic acids
ace
peptides
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1018125.3A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Marealis AS
Original Assignee
Marealis AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Marealis AS filed Critical Marealis AS
Priority to GBGB1018125.3A priority Critical patent/GB201018125D0/en
Publication of GB201018125D0 publication Critical patent/GB201018125D0/en
Priority to AU2011322287A priority patent/AU2011322287B2/en
Priority to JP2013535500A priority patent/JP5879356B2/ja
Priority to EP11738267.1A priority patent/EP2632937B8/en
Priority to RU2013124991/04A priority patent/RU2572623C2/ru
Priority to US13/880,883 priority patent/US9044511B2/en
Priority to CA2856153A priority patent/CA2856153C/en
Priority to CN201180059041.2A priority patent/CN103249741B/zh
Priority to DK11738267.1T priority patent/DK2632937T3/en
Priority to PCT/GB2011/051314 priority patent/WO2012056205A1/en
Priority to BR112013009679-9A priority patent/BR112013009679B1/pt
Priority to US14/709,190 priority patent/US20150315236A1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/142—Amino acids; Derivatives thereof
    • A23K20/147—Polymeric derivatives, e.g. peptides or proteins
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/612—Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0802—Tripeptides with the first amino acid being neutral
    • C07K5/0812—Tripeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Food Science & Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Vascular Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1018125.3A 2010-10-26 2010-10-26 Peptide Ceased GB201018125D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1018125.3A GB201018125D0 (en) 2010-10-26 2010-10-26 Peptide
BR112013009679-9A BR112013009679B1 (pt) 2010-10-26 2011-07-13 uso de peptídeo, composições farmacêuticas e nutracêuticas, alimento ou produto de alimentação e seu processo de fabricação
RU2013124991/04A RU2572623C2 (ru) 2010-10-26 2011-07-13 Пептид
JP2013535500A JP5879356B2 (ja) 2010-10-26 2011-07-13 ペプチド
EP11738267.1A EP2632937B8 (en) 2010-10-26 2011-07-13 FSY or FTY peptide and compositions and their use
AU2011322287A AU2011322287B2 (en) 2010-10-26 2011-07-13 Peptide
US13/880,883 US9044511B2 (en) 2010-10-26 2011-07-13 Peptide
CA2856153A CA2856153C (en) 2010-10-26 2011-07-13 Fsy or fty peptide, compositions and their use
CN201180059041.2A CN103249741B (zh) 2010-10-26 2011-07-13 肽
DK11738267.1T DK2632937T3 (en) 2010-10-26 2011-07-13 FSY or FTY-peptide and compositions and their use
PCT/GB2011/051314 WO2012056205A1 (en) 2010-10-26 2011-07-13 Peptide
US14/709,190 US20150315236A1 (en) 2010-10-26 2015-05-11 Peptide

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1018125.3A GB201018125D0 (en) 2010-10-26 2010-10-26 Peptide

Publications (1)

Publication Number Publication Date
GB201018125D0 true GB201018125D0 (en) 2010-12-08

Family

ID=43365585

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1018125.3A Ceased GB201018125D0 (en) 2010-10-26 2010-10-26 Peptide

Country Status (11)

Country Link
US (2) US9044511B2 (https=)
EP (1) EP2632937B8 (https=)
JP (1) JP5879356B2 (https=)
CN (1) CN103249741B (https=)
AU (1) AU2011322287B2 (https=)
BR (1) BR112013009679B1 (https=)
CA (1) CA2856153C (https=)
DK (1) DK2632937T3 (https=)
GB (1) GB201018125D0 (https=)
RU (1) RU2572623C2 (https=)
WO (1) WO2012056205A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107337711A (zh) * 2017-07-26 2017-11-10 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Pro‑Hyp及应用和药物组合物
CN107325153A (zh) * 2017-07-26 2017-11-07 盐城卫生职业技术学院 一种抗高血压活性肽Citn‑Hyp‑Pro及应用和药物组合物
JPWO2021059840A1 (ja) * 2019-09-27 2021-10-07 太陽化学株式会社 アンジオテンシン変換酵素阻害剤
TWI890506B (zh) * 2024-06-27 2025-07-11 開曼群島商味丹國際（控股）有限公司 具有抑制ace活性之胜肽及其組合物

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4455303A (en) * 1983-05-24 1984-06-19 The General Hospital Corporation Renin inhibitors
US5545719A (en) 1990-05-01 1996-08-13 Neuromedica, Inc. Nerve growth peptides
RU2084458C1 (ru) * 1993-05-27 1997-07-20 Институт высокомолекулярных соединений РАН Декапептид, обладающий противоопухолевой активностью
JP4879020B2 (ja) * 2003-05-01 2012-02-15 コーネル リサーチ ファウンデイション インコーポレイテッド 細胞に分子を送達する方法及び担体複合体
WO2005007090A2 (en) * 2003-07-03 2005-01-27 President And Fellows Of Harvard College Inhibitors of the map kinase pathway
AU2003253301A1 (en) 2003-07-31 2004-07-14 Franco Felici Peptides mimicking vibrio cholerae o139 capsular polysaccharide and their use to elicit protective immune response
AT502292B1 (de) 2005-05-11 2010-04-15 Avir Green Hills Biotechnology Melanomdiagnose
JP4846799B2 (ja) * 2005-07-05 2011-12-28 バイオテンプト ベー．フェー． 腫瘍の治療
WO2007117444A2 (en) * 2006-03-31 2007-10-18 Yinghe Hu Protein detection by aptamers
HUP0600814A3 (en) * 2006-10-27 2009-08-28 Biostatin Gyogyszerkutato Fejl Peptides for activation of angiogenesis, pharmaceutical compounds containing same and use of these compounds
CN101092450A (zh) * 2007-01-10 2007-12-26 中国人民解放军第三军医大学第一附属医院 与人mhc－ⅰ类分子结合的肝素酶多肽表位
EP3103467A1 (en) * 2008-02-07 2016-12-14 Cornell University Methods for preventing or treating insulin resistance
FR2943346B1 (fr) 2009-03-19 2011-05-06 Univ Paris Curie Peptides modulant l'activite de l'igf-1 et leurs applications
GB201008462D0 (en) 2010-05-20 2010-07-07 Marealis As Process

Also Published As

Publication number Publication date
CN103249741A (zh) 2013-08-14
US20130281358A1 (en) 2013-10-24
CN103249741B (zh) 2015-12-02
JP5879356B2 (ja) 2016-03-08
BR112013009679A2 (pt) 2016-07-12
WO2012056205A1 (en) 2012-05-03
RU2572623C2 (ru) 2016-01-20
JP2014500245A (ja) 2014-01-09
EP2632937A1 (en) 2013-09-04
CA2856153C (en) 2019-04-16
RU2013124991A (ru) 2014-12-10
AU2011322287A1 (en) 2013-05-02
EP2632937B1 (en) 2016-03-16
AU2011322287B2 (en) 2015-06-25
CA2856153A1 (en) 2012-05-03
EP2632937B8 (en) 2016-06-22
US9044511B2 (en) 2015-06-02
BR112013009679B1 (pt) 2020-12-01
DK2632937T3 (en) 2016-05-30
US20150315236A1 (en) 2015-11-05

Similar Documents

Publication Publication Date Title
NZ587105A (en) Tissue protective peptides and peptide analogs for preventing and treating diseases and disorders associated with tissue damage
SA518390954B1 (ar) لقاحات علاجية لفيروس الورم الحليمي البشري 18
MX2012008999A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340015B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX2012009000A (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
MX340016B (es) Composicion farmaceutica para el tratamiento y/o prevencion del cancer.
BR112012029975A2 (pt) peptídeo como medicamento, em particular para o tratamento do câncer.
IN2014KN01713A (https=)
IN2014KN01714A (https=)
IN2014KN01716A (https=)
WO2009080306A8 (en) Anti-dandruff compositions containing peptides
MX359953B (es) Ácido nucleico que comprende o que codifica un tallo-rizo de histona y una secuencia poli (a) o una señal de poliadenilación para incrementar la expresión de una proteína terapéutica codificada.
NZ603200A (en) Peptides and their use
MX344219B (es) Productos farmaceuticos peptidicos mejorados para resistencia a insulina.
EP3412304A3 (en) Hla-a24 agonist epitopes of muc1-c oncoprotein and compositions and methods of use
UA100127C2 (ru) Пептид cdh3 и лекарственное средство, содержащее его
MX2009004243A (es) Nuevas proteinas h5, moleculas de acido nucleico y vectores que las codifican y su uso medicinal.
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
MX2014004953A (es) Ligadores basados en tirosina para la conexion desprendible de peptidos.
NZ609916A (en) Hla-binding peptides derived from prostate-associated antigenic molecules and methods of use thereof
NZ708990A (en) Method for activating helper t cell
IN2014DN09963A (https=)
NZ610620A (en) Inhibitors of apoptosis and uses thereof
MX2008009493A (es) Peptido novedoso y uso del mismo.
NZ703514A (en) Fviii peptides for immune tolerance induction and immunodiagnostics

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)